Your browser is no longer supported. Please, upgrade your browser.
Settings
LH Laboratory Corporation of America Holdings daily Stock Chart
LH [NYSE]
Laboratory Corporation of America Holdings
IndexS&P 500 P/E48.69 EPS (ttm)3.67 Insider Own0.40% Shs Outstand97.30M Perf Week-3.58%
Market Cap17.37B Forward P/E11.43 EPS next Y15.64 Insider Trans-7.88% Shs Float96.84M Perf Month-0.22%
Income362.20M PEG5.77 EPS next Q4.89 Inst Own93.70% Short Float1.46% Perf Quarter13.74%
Sales11.47B P/S1.51 EPS this Y-7.70% Inst Trans-0.77% Short Ratio1.75 Perf Half Y45.48%
Book/sh75.57 P/B2.36 EPS next Y8.19% ROA2.00% Target Price228.47 Perf Year4.84%
Cash/sh5.73 P/C31.19 EPS next 5Y8.44% ROE5.00% 52W Range98.02 - 206.74 Perf YTD5.62%
Dividend- P/FCF14.80 EPS past 5Y7.10% ROI7.50% 52W High-13.57% Beta1.26
Dividend %- Quick Ratio1.00 Sales past 5Y14.00% Gross Margin27.20% 52W Low82.29% ATR4.76
Employees65000 Current Ratio1.10 Sales Q/Q-51.20% Oper. Margin6.80% RSI (14)41.25 Volatility2.64% 2.69%
OptionableYes Debt/Eq0.86 EPS Q/Q-37.90% Profit Margin3.20% Rel Volume0.87 Prev Close184.90
ShortableYes LT Debt/Eq0.75 EarningsJul 28 BMO Payout0.00% Avg Volume808.09K Price178.68
Recom1.80 SMA20-0.47% SMA50-4.23% SMA2004.74% Volume702,987 Change-3.36%
Jul-14-20Upgrade BofA Securities Neutral → Buy $194 → $220
Jul-13-20Upgrade Wolfe Research Peer Perform → Outperform
Jun-02-20Resumed Deutsche Bank Buy $210
May-15-20Upgrade Mizuho Neutral → Buy $158 → $186
Apr-29-20Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Apr-27-20Upgrade Wolfe Research Underperform → Peer Perform
Apr-27-20Upgrade Citigroup Neutral → Buy $204 → $214
Jan-08-20Initiated Wells Fargo Overweight $210
Jul-16-19Upgrade BofA/Merrill Underperform → Neutral
Jun-21-19Upgrade Deutsche Bank Hold → Buy $180 → $220
Apr-02-19Upgrade Jefferies Hold → Buy $154 → $190
Jan-17-19Initiated UBS Buy $169
Jan-03-19Downgrade BofA/Merrill Neutral → Underperform
Dec-03-18Downgrade Craig Hallum Buy → Hold
Oct-30-18Downgrade Argus Buy → Hold
Oct-25-18Downgrade Canaccord Genuity Buy → Hold $190 → $162
Oct-19-18Resumed BofA/Merrill Buy
Jun-07-18Upgrade KeyBanc Capital Mkts Sector Weight → Overweight
May-01-18Upgrade Robert W. Baird Neutral → Outperform
Mar-23-18Initiated Argus Buy $202
Sep-23-20 06:56AM  
Sep-21-20 05:50PM  
Sep-16-20 06:58AM  
Sep-14-20 05:50PM  
Sep-09-20 08:08AM  
Sep-08-20 07:24AM  
Sep-03-20 05:50PM  
Sep-02-20 09:53AM  
Sep-01-20 04:23PM  
12:17AM  
Aug-31-20 01:30PM  
Aug-28-20 05:50PM  
11:43AM  
Aug-27-20 03:40PM  
11:31AM  
Aug-26-20 02:59PM  
Aug-21-20 04:18PM  
Aug-20-20 08:02AM  
Aug-14-20 12:28PM  
Aug-11-20 07:00AM  
Aug-10-20 08:00AM  
Aug-06-20 12:55PM  
Aug-04-20 11:59AM  
Aug-03-20 11:05AM  
Jul-31-20 12:13PM  
Jul-30-20 03:43PM  
03:26PM  
10:02AM  
09:55AM  
09:23AM  
09:20AM  
Jul-29-20 09:54AM  
09:15AM  
Jul-28-20 03:30PM  
03:00PM  
11:41AM  
11:30AM  
10:21AM  
08:25AM  
07:00AM  
06:49AM  
Jul-27-20 10:38AM  
Jul-26-20 12:28PM  
Jul-25-20 10:14AM  
Jul-24-20 11:40AM  
Jul-21-20 12:31PM  
10:10AM  
09:56AM  
Jul-20-20 11:06AM  
09:31AM  
Jul-16-20 12:10PM  
Jul-15-20 11:01AM  
11:01AM  
08:56AM  
Jul-13-20 09:33AM  
Jul-10-20 10:23AM  
Jul-09-20 07:04AM  
Jul-08-20 12:33PM  
08:48AM  
08:39AM  
07:46AM  
Jul-07-20 06:32PM  
11:40AM  
10:24AM  
10:21AM  
07:58AM  
Jul-06-20 04:25PM  
10:04AM  
10:02AM  
08:49AM  
Jul-03-20 09:39AM  
08:30AM  
Jul-02-20 08:46AM  
Jul-01-20 08:59AM  
08:49AM  
Jun-30-20 11:12AM  
09:37AM  
06:57AM  
Jun-29-20 08:20AM  
07:01AM  
Jun-26-20 10:03AM  
08:40AM  
Jun-25-20 01:09PM  
12:52PM  
08:27AM  
07:59AM  
07:53AM  
07:07AM  
Jun-24-20 08:43AM  
07:00AM  
Jun-23-20 10:03AM  
09:24AM  
07:19AM  
Jun-22-20 07:43AM  
Jun-19-20 09:13AM  
Jun-18-20 11:40AM  
09:39AM  
Jun-17-20 07:36PM  
06:28AM  
Jun-16-20 09:46AM  
Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, LabCorp Diagnostics (LCD) and Covance Drug Development. It offers various clinical laboratory tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually-transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides testing services in the areas of women's health, allergy, diagnostic genetics, cardiovascular and infectious disease, endocrinology, oncology, coagulation, pharmacogenetics, toxicology, and medical drug monitoring; and esoteric testing, cancer diagnostics, and other procedures. In addition, it provides a suite of applications to enable patients, healthcare providers, health systems, accountable care organizations, and insurers with access to LCD's data and services, as well as billing for laboratory services. Further, it offers end-to-end drug development, medical device, and diagnostic development solutions from research to clinical development and commercial market access. The company primarily serves managed care organizations, biopharmaceutical companies, physicians and other healthcare providers, hospitals and health systems, governmental agencies, employers, patients and consumers, contract research organizations, academic institutions, and independent clinical laboratories. Laboratory Corporation of America Holdings has collaborations with the Boston University, Columbia University, Duke University, Johns Hopkins University, The Mount Sinai Hospital, the University of Tennessee, Yale University, and QIAGEN N.V; and Ciox Health for the creation of COVID-19 patient data registry in the United States. The company was founded in 1971 and is headquartered in Burlington, North Carolina.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Williams R SandersDirectorJul 08Option Exercise98.491,300128,0376,395Jul 10 04:25 PM
Williams R SandersDirectorJul 08Sale173.121,300225,0565,095Jul 10 04:25 PM
van der Vaart Sandra DEVP, Chief Legal OfficerJul 02Sale170.0043573,9504,044Jul 07 09:38 AM
van der Vaart Sandra DEVP, Chief Legal OfficerJun 24Sale160.33872139,8084,479Jun 26 10:06 AM
KING DAVID PDirectorMay 05Sale160.0031,2505,000,000312,554May 07 12:05 PM
Kirchgraber Paul RCEO, Covance Drug DevelopmentApr 03Option Exercise0.001,01008,459Apr 07 04:21 PM
Seltz Judith CEVP, CHROMar 10Buy168.5633055,625580May 04 10:18 AM
Seltz Judith CEVP, CHROFeb 28Buy174.9425043,735250May 04 10:18 AM
Wilkinson Peter JSVP, Chief Accounting OfficerFeb 21Sale189.6529756,326297Feb 25 12:59 PM
BELINGARD JEAN-LUCDirectorFeb 19Option Exercise77.193,100239,28941,161Feb 21 03:52 PM
BELINGARD JEAN-LUCDirectorFeb 19Sale189.7626,4795,024,75014,682Feb 21 03:52 PM
Williams R SandersDirectorFeb 13Sale188.491,227231,2775,095Feb 14 03:08 PM
van der Vaart Sandra DSVP, Global General CounselFeb 13Sale188.4920839,2062,736Feb 14 05:11 PM
Schroeder Mark SEVP, President-Diagnostics LabFeb 13Sale188.4918835,436486Feb 14 05:07 PM
Schroeder Mark SEVP, President-Diagnostics LabFeb 10Sale181.9910819,655300Feb 11 01:47 PM
van der Vaart Sandra DSVP, Global General CounselFeb 10Sale181.9913324,2052,529Feb 11 01:45 PM
KING DAVID PPresident & CEOOct 28Sale165.4030,1774,991,217305,933Oct 30 05:25 PM